Aspen will spend a record sum on transforming its Port Elizabeth manufacturing site, marking the ‘single biggest pharmaceutical investment’ in South Africa to date.
Australia’s largest clinical CRO Novotech has expanded its clinical services with a new office in Johannesburg, South Africa to deal with increasing sponsor demand.
US drugmaker Merck & Co’s new deal with Adcock Ingram proves the FIFA football World Cup isn’t the only thing attracting people to South Africa this summer.
Adcock Ingram recorded an 11 per cent rise in profit in the first half of 2010 and is looking to continue this upwards trend through manufacturing expansions, plus local and overseas acquisitions.